N Kleiman

Author PubWeight™ 10.24‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators. N Engl J Med 1990 2.73
2 Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. JAMA 1996 1.99
3 Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet 1999 1.68
4 Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience. Neurology 1995 0.90
5 Heparin-induced prolongation of partial thromboplastin time after thrombolysis: relation to coronary artery patency. HART Investigators. J Am Coll Cardiol 1992 0.85
6 Relation of left ventricular dilation during acute myocardial infarction to systolic performance, diastolic dysfunction, infarct size and location. Am J Cardiol 1988 0.82
7 Confronting the issues of patient safety and investigator conflict of interest in an international clinical trial of myocardial reperfusion. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO) Steering Committee. J Am Coll Cardiol 1992 0.77
8 Anticoagulant therapy in acute myocardial infarction: demonstration of a selection bias in a retrospective study. Thromb Res 1980 0.76
9 Platelet activation in acute myocardial infarction and the rationale for combination therapy. Curr Cardiol Rep 2000 0.75
10 Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deployment. Circulation 1997 0.75
11 [Prognostic significance of initial blood glucose levels in acute myocardial infarction]. Harefuah 1982 0.75
12 Thrombolytic treatment for acute myocardial infarction. Tex Med 1988 0.75
13 Hypertrophic obstructive cardiomyopathy: alternative therapeutic options. Clin Cardiol 1997 0.75
14 Helicopter transport of patients with acute myocardial infarction. Tex Med 1988 0.75
15 Detection of transplant arteriopathy: does exercise thallium scintigraphy improve noninvasive diagnostic capabilities? Transplant Proc 1991 0.75
16 Lack of usefulness of prolonged bleeding times in predicting hemorrhagic events in patients receiving the 7E3 glycoprotein IIb/IIIa platelet antibody. The TAMI Study Group. Am J Cardiol 1993 0.75